Nov 20, 2019 / 02:00PM GMT
Operator
Greetings, and welcome to the KOL call on mastocytosis hosted by AB Sciences. (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Mr. Alain Moussy, CEO of AB Sciences. Thank you. You may begin.
Alain Moussy - AB Science S.A. - Co-Founder, Chairman, President, CEO & Scientific Director
Thank you, and good afternoon and good morning to the participants. My name is Alain Moussy. I'm the CEO of AB Science, and it is my pleasure to welcome you to this web conference to present to you (inaudible) masitinib in indolent systemic mastocytosis.
I will move to you slide by slide. So I declare, of course, our usual disclaimer in the presentation. And the agenda will be structured in different parts today. We will introduce the participants, the KOL. We will give you the drug results with masitinib in indolent systemic mastocytosis. Then we will look at the standard design of the confirmatory study, and then we will give the tribune to the KOL who are joining us during the call. And
AB Science SA on Indolent Systemic Mastocytosis - Conference Call Transcript
Nov 20, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers